Our findings show that COVID-19 patients undergoing IMV are mainly associated with the group with high systemic TNF levels; however, only the group with increased TNF/IFN-γ levels had significantly increased molecules associated with signaling to produce proinflammatory cytokines, which may enhance the development of the cytokine storm and cell death. The gene discussed is TNF; the disease is COVID-19.